An enzyme-linked immunosorbent assay was developed to detect antibodies to infectious bovine rhinotracheitis virus in bovine sera. The test used viral antigen purified in a sucrose density gradient, and the antibody titers detected were up to 100 times higher than those seen in the serum neutralization test. When 250 sera were tested by those two tests, 146 were positive and 49 were negative in both tests. Only 1 serum was negative in the immunoassay test and positive in the neutralization test. However, 54 sera negative in the neutralization test were positive in the immunoassay test. These positive results appear to be in agreement with the increased sensitivity of the enzyme immunoassay.
The measurement of antibodies to infectious bovine rhinotracheitis (IBR) virus after a natural infection or after vaccination is usually based on the serum neutralization (SN) test (2) . In 1975 we reported (1) that immunofluorescence was a suitable and faster alternative. More recently the development of new immunoenzymatic assays for several animal infections (4) prompted us to investigate an enzyme-linked immunosorbent assay (ELISA) test for the measurement of antibodies in certain viral infections. We have already reported its successful use for the serology of pneumonia virus of mice (3), and we are now reporting its use for the serology of IBR virus, using semipurified virus as the antigen.
MATERIALS AND METHODS
Virus and cell culture. Primary and secondary bovine testis cell cultures were grown in lactalbumin hydrolysate medium containing 4% fetal bovine serum. The Colorado strain (passage 36) of IBR virus was used at 1,000 50% tissue culture infective doses to infect the confluent monolayers. Lactalbumin hydrolysate medium without fetal bovine serum was used as maintenance medium. When the cytopathic effect involved 90% of the monolayer, about 48 h later, the cultures were frozen and thawed (-70°C, 37°C) three times.
Viral antigen preparation for ELISA. Frozen and thawed infected or uninfected cell culture fluids were adjusted to 1.0 M NaCl and 8% polyethylene glycol (molecular weight, 6,000). The mixture was agitated for 2 h at 4°C, and the precipitate was then recovered by centrifugation at 3,000 x g for 30 min. The pellet was resuspended in saline to 'Ao of the original volume.
The concentrated viral and control preparations were sonicated for 1 min at 100 W/cm2, using the microprobe of a model 1510 Bransonic sonicator. Five milliliters of this material was added to 15 ml of NTE buffer (0.15 M NaCl, 0.01 M tris(hydroxymethyl)aminomethane-hydrochloride, 0.001 M ethylenediaminetetraacetate, pH 7.8) and placed on a discontinuous sucrose gradient formed by layering 10 ml of 30% (wt/wt) sucrose and 10 ml of 50% sucrose in NTE buffer in a 40-ml tube. This preparation was centrifuged at 25,000 rpm in an SW-27 rotor for 2 h. Two-milliliter fractions were recovered. The 30%-50% sucrose interface contained the viral antigen. The same fractions from uninfected material were used as control antigen.
ELISA procedure. The ELISA assay was set up as described by Voller et When individual results were plotted on a graph correlating the two tests (Fig. 2) It is suggested that the ELISA-IBR test could be efficiently applied to the diagnosis of IBR virus infections because of its greater sensitivity, which permits the detection of a larger number of positive sera as compared with the SN test. Furthermore, the test is less expensive and timeconsuming and can be used to titrate rapidly a large number of sera.
